Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(14):1020-1021; doi:10.1093/jnci/djj279
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kunkler, I.
Right arrow Articles by Bartlett, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunkler, I.
Right arrow Articles by Bartlett, J.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press.

CORRESPONDENCE

Re: Survival Effects of Postmastectomy Adjuvant Radiation Therapy Using Biologically Equivalent Doses: A Clinical Perspective

Ian Kunkler, Nicola Russell, Peter Canney, Karen Venables, John Bartlett

The first 10% of the full text of this article appears below.

We agree with Gebski et al. (1) that adequate dosage and target area for adjuvant postmastectomy radiation therapy are important for optimal locoregional control. We would, however, disagree with their statement that "it is now generally accepted that the target volume should include the chest wall and the peripheral lymphatics." The Danish trials (. . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

RESPONSE: Re: Survival Effects of Postmastectomy Adjuvant Radiation Therapy Using Biologically Equivalent Doses: A Clinical Perspective
Val Gebski, Marivic Lagleva, Anthony Keech, John Simes, and Allan Langlands
J Natl Cancer Inst 2006 98: 1021-1022. [Extract] [Full Text] [PDF]